HPV DNA Vaccine Via Electroporation for HPV16 Positive Cervical Neoplasia

Recruiting

Phase 1

HPV DNA VaccineHPV DNA Vaccine Via Electroporation for HPV16 Positive Cervical Neoplasia

Sponsor:

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Code:

NCT04131413

Conditions

Human Papillomavirus Type 16

Cervical Intraepithelial Neoplasia Grade II

Cervical Intraepithelial Neoplasia, Grade III

Eligibility Criteria

Sex: Female

Age: 19+

Healthy Volunteers: Accepted

Interventions

pNGVL4aCRTE6E7L2

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-09-18. This information was provided to ClinicalTrials.gov by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins on 2025-08-24.